USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
REVERAGEN BIOPHARMA, INC.
Address:
9700 GREAT SENECA HWY, STE 160
ROCKVILLE, MD 20850-
Phone:
N/A
URL:
N/A
EIN:
126380841
DUNS:
802841069
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $178,857.00 1

Award List:

Anti-inflammatory and Mitotic Properties of Non-hormonal Steroids in Lung Epithel

Award Year / Program / Phase:
2010 / STTR / Phase I
Award Amount:
$178,857.00
Agency:
HHS
Principal Investigator:
Erica Reeves – 240-401-9434
Research Institution:
Children'S National Medical Center
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Asthma is a very common lung condition in children, and incidence is increasing in the US particularly in urban and minority populations. The standard of care for asthmatics is inhaled steroid, although clinical response is variable. The mechanism of efficacy of… More